Roivant Sciences Ltd.(ROIV)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ROIV Roivant Sciences Ltd.

休市中 01-03 16:00:00 EST

11.69

-0.39

-3.23%

盘后12.03

+0.34+2.91%

19:58 EST

最高12.15	最低11.66	成交量338.38万
今开12.13	昨收12.08	日振幅4.06%
总市值85.10亿	流通市值43.88亿	总股本7.28亿
成交额4,008万	换手率0.90%	流通股本3.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":11.69,"timestamp":1735938000000,"preClose":12.08,"halted":0,"volume":3383774,"hourTrading":{"tag":"盘后","latestPrice":12.03,"preClose":11.69,"latestTime":"19:58 EST","volume":64558,"amount":763069.6431,"timestamp":1735952337684},"delay":0,"floatShares":375381189,"shares":727949744,"eps":5.886067,"marketStatus":"休市中","change":-0.39,"latestTime":"01-03 16:00:00 EST","open":12.13,"high":12.15,"low":11.66,"amount":40084230.793062,"amplitude":0.040563,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.886067,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1736154000000},"marketStatusCode":7,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":12.08,"preHourTrading":{"tag":"盘前","latestPrice":12.13,"preClose":12.08,"latestTime":"09:29 EST","volume":1679,"amount":20335.233685,"timestamp":1735914599999},"postHourTrading":{"tag":"盘后","latestPrice":12.03,"preClose":11.69,"latestTime":"19:58 EST","volume":64558,"amount":763069.6431,"timestamp":1735952337684},"volumeRatio":0.872305,"impliedVol":0.2569,"impliedVolPercentile":0.2579},"requestUrl":"/m/hq/s/ROIV/wiki","defaultTab":"wiki","newsList":[{"id":"2488249239","title":"嗡嗡声--美国股票走势-PSQ Holdings、Core Scientific、Keros","url":"https://stock-news.laohu8.com/highlight/detail?id=2488249239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488249239?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:41","pubTimestamp":1733251314,"startTime":"0","endTime":"0","summary":"** Credo Technology Group Holding Ltd   : BUZZ - 因第二季度销售额超出预期而大涨   ** Janux Therapeutics Inc   : BUZZ - 因癌症药物的早期数据超出预期而飙升。** Core Scientific Inc   : BUZZ - 在扩大 5.5 亿美元可转换债券发行规模后上涨   ** Keros Therapeutics Inc   : BUZZ - 与武田达成血癌药物许可协议后上涨   ** AT&T Inc   : BUZZ - 在实施扩张计划和提高指导后创下 3 年半新高   ** Rio Tinto PLC   ：** BHP Group Ltd   ：** Southern Copper Corp   ：** Freeport-McMoRan Inc   : BUZZ - 铜矿企业因美元走软而上涨   ** Avadel Pharmaceuticals PLC   : BUZZ - 在首席商务官辞","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","FDN","AVDL","AZO","CUZ","DDM","FCX","FDX","TRGP","TERN","LYV","CTRN","JANX","JBGS",".IXIC","KROS","UDOW","DXD","X","CPNG","CORZ","SCCO","ZS","NEM","DJX","PSQH","KR","T","DOG","MP","XOM",".DJI","INTC","EQT","BLK","DECK","SDOW","LTRN","MOH","CHRS","ADM","CVX","ROIV","AXON","OLLI"],"gpt_icon":1},{"id":"2488942699","title":"嗡嗡声--美国股票走势-贝莱德、Terns Pharma、PSQ Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2488942699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488942699?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:50","pubTimestamp":1733241022,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.29%，报44,650.91点；标准普尔500指数.SPX下跌0.20%，报6,034.81点；纳斯达克综合指数.IXIC下跌0.10%，报19,384.43点。标准普尔500指数.PG.INX涨幅前三名是： ** Palantir Technologies Inc PLTR.OQ，上涨 5.4. nL3N3N414G  ** Credo Technology Group Holding Ltd CRDO.O:BUZZ - 因第二季度销售额超出预期而大涨 nL3N3N40QR  ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N419A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","MCHP","X","LEV","ZS","OLLI","TCS","LU1861220033.SGD","FDX","BK4114","AZO","CZR","BK4187","BLK","CTNT","MPLN","AXON","CRDO","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","PCG","BK4168","LU1923622291.USD","MP","NEM","CANG","CTRN","LU2430703095.HKD","T","BK4135","LTRN","TERN","AMGN","CTXR","DECK","LU2125909759.SGD","ATIP","PSQH","XCUR","CHRS","CPNG","OMEX","LU2264538146.SGD","LYV","KR","JANX"],"gpt_icon":1},{"id":"2488491948","title":"嗡嗡声--美国股票走势-花旗趋势、PG&E、贝莱德","url":"https://stock-news.laohu8.com/highlight/detail?id=2488491948","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488491948?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:05","pubTimestamp":1733234739,"startTime":"0","endTime":"0","summary":"nL3N3N40QR  ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。nL3N3N40RX  ** FedEx Corp FDX.N:BUZZ - 伯恩斯坦在发布第二季度财报前将联邦快递的评级下调至 \"市场表现\"。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N410V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4170","BLK","LU0122379950.USD","FDX","JANX","LU1280957306.USD","PCG","CHRS","CTNT","AMGN","BK4097","X","LU0345770308.USD","AXON","BK4559","LYV","IE00B3PB1722.GBP","LU0320765489.SGD","DECK","LU0251142724.SGD","LU1670627923.USD","NEM","BK4539","BK4533","LU0345770993.USD","LU0724618789.USD","LU0788109121.HKD","LU1430597077.USD","LU1983299246.USD","CTRN","LU2264538146.SGD","BK4535","LU2112291526.USD","LU0390134368.USD","MP","BK4159","ZS","IE00BFTCPJ56.SGD","LU0300736062.USD","LU1861215975.USD","LU2242652126.USD","LTRN","KR","LU0070302665.USD","LU1989771016.USD","LU0109394709.USD","CRDO","LU1064131342.USD","ROIV"],"gpt_icon":0},{"id":"2488917615","title":"试验失败后，Roivant 将停止肺病药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917615","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488917615?lang=zh_cn&edition=full","pubTime":"2024-12-03 21:32","pubTimestamp":1733232769,"startTime":"0","endTime":"0","summary":"更新 2-试验失败后，Roivant 将停止肺病药物开发第5段增加了首席执行官的话，第2段增加了试验细节，更新了股价路透社12月3日 - Roivant ROIV.O将停止开发治疗一种罕见肺病的药物，因为该药物在一项中期试验中未能显示出对患者的治疗效果。Roivant公司的股票在盘前交易中下跌了2.3%。药物开发商aTyr Pharma的ATYR.O efzofitimod也正在接受治疗肺肉样肿病的测试，目前处于后期开发阶段。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3T3N40Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2485145218","title":"Roivant Sciences Ltd.盘中异动 下午盘快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485145218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485145218?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:35","pubTimestamp":1732300530,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时35分，Roivant Sciences Ltd.股票出现异动，股价急速上涨5.03%。截至发稿，该股报12.42美元/股，成交量625.79万股，换手率0.86%，振幅5.37%。Roivant Sciences Ltd.股票所在的生物技术行业中，整体涨幅为0.82%。Roivant Sciences Ltd.公司简介：Roivant Sciences Ltd是一家处于商业阶段的生物制药公司，致力于改善向患者提供医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123023530a24e829e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123023530a24e829e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2485812296","title":"马斯克、拉马斯瓦米将依靠最高法院的裁决削减联邦机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2485812296","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485812296?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:57","pubTimestamp":1732132676,"startTime":"0","endTime":"0","summary":"特斯拉TSLA.O和SpaceX公司的首席执行官、亿万富翁马斯克和前共和党总统候选人、生物技术公司Roivant Sciences ROIV.O的创始人拉马斯瓦米受当选总统特朗普的委托， ，领导一个外部顾问小组提出提高效率的建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4S3MR1HM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1XK9C88.USD","BK4555","LU1852331112.SGD","BK4550","SG9999015978.USD","SG9999015945.SGD","LU2249611893.SGD","LU1914381329.SGD","LU2023250330.USD","ROIV","LU1551013425.SGD","LU1548497426.USD","LU1720051108.HKD","LU1861215975.USD","LU2602419157.SGD","BK4585","LU2213496289.HKD","BK4574","BK4511","BK4139","SG9999015952.SGD","LU1861559042.SGD","LU0820562030.AUD","BK4551","LU0348723411.USD","TSLA","IE00BJLML261.HKD","LU0316494557.USD","LU1145028129.USD","LU0198837287.USD","BK4007","LU2087621335.USD","IE00BSNM7G36.USD","BK4588","LU0820561909.HKD","LU0234572021.USD","LU1839511570.USD","LU1429558221.USD","LU1720051017.SGD","LU2357305700.SGD","LU0466842654.USD","LU0053666078.USD","LU0823411888.USD","LU0056508442.USD","LU0943347566.SGD","BK4527","LU0082616367.USD","BK4598","LU0820561818.USD","LU2756315664.SGD"],"gpt_icon":1},{"id":"2485126726","title":"马斯克和拉马斯瓦米计划依靠最高法院的裁决来减少联邦机构的管辖范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2485126726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485126726?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:46","pubTimestamp":1732128367,"startTime":"0","endTime":"0","summary":"\"马斯克和拉马斯瓦米写道：\"DOGE 将向特朗普总统提交这份法规清单，特朗普总统可以通过行政措施立即暂停执行这些法规，并启动审查和废除程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","IE00BSNM7G36.USD","IE00BJLML261.HKD","SG9999015952.SGD","LU0943347566.SGD","BK4555","LU0234572021.USD","LU2023250330.USD","LU0689472784.USD","LU1861559042.SGD","SG9999015978.USD","BK4592","BK4007","LU0234570918.USD","LU1429558221.USD","BK4581","LU0316494557.USD","LU1145028129.USD","LU1852331112.SGD","LU0823414478.USD","BK4598","LU0719512351.SGD","LU2087621335.USD","LU2213496289.HKD","TSLA","LU0198837287.USD","ROIV","LU2756315318.SGD","LU0820561818.USD","LU0097036916.USD","LU0082616367.USD","BK4527","SG9999015945.SGD","LU1861558580.USD","LU0820561909.HKD","BK4516","LU1914381329.SGD","LU2756315664.SGD","LU1435385759.SGD","LU1861215975.USD","LU1629891620.HKD","BK4533","LU2602419157.SGD","LU0823411888.USD","BK4139","LU1720051017.SGD","BK4588","LU2326559502.SGD","LU1551013425.SGD","LU2249611893.SGD"],"gpt_icon":1},{"id":"2483203887","title":"讲解员-马斯克的美国政府效率小组可能如何运作","url":"https://stock-news.laohu8.com/highlight/detail?id=2483203887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483203887?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:21","pubTimestamp":1731511316,"startTime":"0","endTime":"0","summary":"尽管当选总统对该小组的运作方式知之甚少，但马斯克此前已制定了削减 2 万亿美元开支的宏伟目标。特朗普和马斯克曾表示，该小组将能够进行大幅削减，但一般来说，大型预算行动属于国会的职权范围。为了做到透明，马斯克表示，该小组将公布其 \"行动\"，供公众评论。2017年3月，特朗普签署了一项行政命令，旨在提高联邦机构的效率、效力和问责制，并 \"取消或重组不必要的联邦机构\"。马斯克在太空领域取得了更大的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d6b7a435638da93246285db3076023d0","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","BK4139","BK4548","BK4574","LU2357305700.SGD","LU0820562030.AUD","LU1551013425.SGD","BK4585","LU1551013342.USD","LU0053666078.USD","BK4588","LU0348723411.USD","LU1720051017.SGD","BK4550","TSLA","IE00B1XK9C88.USD","BK4527","LU2249611893.SGD","LU2023250330.USD","LU0097036916.USD","LU1852331112.SGD","BK4533","LU1629891620.HKD","LU1861215975.USD","BK4581","BK4099","LU0316494557.USD","LU2087621335.USD","BK4007","SG9999015945.SGD","LU1914381329.SGD","LU1839511570.USD","LU0820561818.USD","LU2756315664.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU1548497426.USD","BK4551","BK4534","ROIV","LU1861558580.USD","LU0964807845.USD","LU2602419157.SGD","LU2756315318.SGD","SG9999015952.SGD","BK4592","LU0719512351.SGD","LU2063271972.USD","LU2326559502.SGD","LU1720051108.HKD"],"gpt_icon":1},{"id":"2468583567","title":"BUZZ-Roivant因Organon同意以高达12亿美元的价格收购其部门而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2468583567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468583567?lang=zh_cn&edition=full","pubTime":"2024-09-18 20:20","pubTimestamp":1726662022,"startTime":"0","endTime":"0","summary":"    9月18日 - ** Roivant Sciences   股价盘前上涨2.5%至12.35美元** 医疗保健公司Organon   称， ，该公司已同意以12亿美元收购皮肤疗法开发商Dermavant。** 该交易将使 OGN 获得 Dermavant 的银屑病药膏 VTAMA，该药膏于 2022 年 5 月获得美国 FDA 批准。** 作为交易的一部分，OGN 将支付 1.75 亿美元的预付款以及高达 9.5 亿美元的里程碑付款** OGN 预计在今年第四季度完成交易** 截至上次收盘，ROIV 股价年累计上涨 7.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065169927.USD","LU2065171311.SGD","BK4559","OGN","ROIV","LU2065170008.USD","BK4585","BK4139","LU2065171402.SGD","BK4007"],"gpt_icon":0},{"id":"2468300195","title":"更新版 1-Organon 拟以高达 12 亿美元的价格收购皮肤疗法开发商 Dermavant","url":"https://stock-news.laohu8.com/highlight/detail?id=2468300195","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468300195?lang=zh_cn&edition=full","pubTime":"2024-09-18 19:55","pubTimestamp":1726660516,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第 2-4 段增加了交易细节)    路透9月18日 - 医疗保健公司Organon   周三表示，已同意以不超过12亿美元的价格收购Roivant   旗下皮肤疗法开发商Dermavant。Organon公司将支付1.75亿美元的预付款，以及7500万美元的里程碑付款，在达到某些商业里程碑时最高支付9.5亿美元。Dermavant 的 VTAMA 银屑病膏于 2022 年 5 月获得美国食品和药物管理局批准。银屑病是一种常见的慢性炎症性皮肤病。公司预计将在今年第四季度完成交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4585","ROIV","LU2065170008.USD","LU2065171402.SGD","BK4588","BK4139","LU2065169927.USD","BK4007","OGN","LU2065171311.SGD"],"gpt_icon":0},{"id":"2468307175","title":"Organon 将以高达 12 亿美元的价格收购疗法开发商 Dermavant","url":"https://stock-news.laohu8.com/highlight/detail?id=2468307175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468307175?lang=zh_cn&edition=full","pubTime":"2024-09-18 19:37","pubTimestamp":1726659434,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月18日 - 医疗保健公司Organon   周三表示，已同意以不超过12亿美元的价格收购Roivant   旗下的Dermavant公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4585","OGN","ROIV","BK4139","BK4007","LU2065171402.SGD","BK4588","LU2065169927.USD","LU2065170008.USD","BK4559"],"gpt_icon":0},{"id":"2460736683","title":"Roivant Sciences Ltd.2024财年第二财季实现净利润95.30百万美元，同比增加132.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736683","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736683?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:00","pubTimestamp":1723910430,"startTime":"0","endTime":"0","summary":"8月18日，Roivant Sciences Ltd.公布财报，公告显示公司2024财年第二财季净利润为95.30百万美元，同比增加132.64%；其中营业收入为55.13百万美元，同比增加155.00%，每股基本收益为0.13美元。从资产负债表来看，Roivant Sciences Ltd.总负债6.01亿美元，其中短期债务21.49百万美元，资产负债比为10.81，流动比率为27.92。机构评级：截至2024年8月18日，当前有9家机构对Roivant Sciences Ltd.目标价做出预测，其中目标均价为16.67美元，其中最低目标价为12.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180000529f34026f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180000529f34026f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ROIV"],"gpt_icon":0},{"id":"2458341167","title":"Roivant Sciences Ltd.盘中异动 大幅上涨5.01%报10.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458341167","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458341167?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:33","pubTimestamp":1723134784,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时33分，Roivant Sciences Ltd.股票出现异动，股价急速拉升5.01%。截至发稿，该股报10.68美元/股，成交量261.747万股，换手率0.35%，振幅6.24%。Roivant Sciences Ltd.股票所在的生物技术行业中，整体涨幅为2.93%。Roivant Sciences Ltd.公司简介：Roivant Sciences Ltd是一家处于商业阶段的生物制药公司，致力于改善向患者提供医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809003304941ff810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809003304941ff810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.roivant.com","stockEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":-0.0347},{"period":"3month","weight":0.0272},{"period":"6month","weight":0.0977},{"period":"1year","weight":0.0804},{"period":"ytd","weight":-0.0118}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Roivant Sciences Ltd.是一家于2020年7月6日成立的注册于百慕大群岛的公司。Roivant的使命是通过将每一个低效率都视为机会来改善为患者提供的医疗保健服务。Roivant通过以创造性的方式构建技术和培养人才，利用Roivant平台推出“Vants”——灵活且专注的生物制药和健康技术公司，从而更快地开发变革性药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.075666},{"month":2,"riseRate":0.25,"avgChangeRate":0.003027},{"month":3,"riseRate":0,"avgChangeRate":-0.105559},{"month":4,"riseRate":0.75,"avgChangeRate":-0.013041},{"month":5,"riseRate":0.5,"avgChangeRate":0.053964},{"month":6,"riseRate":0.75,"avgChangeRate":0.012477},{"month":7,"riseRate":0.75,"avgChangeRate":0.048723},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002132},{"month":9,"riseRate":0.25,"avgChangeRate":-0.05068},{"month":10,"riseRate":0.5,"avgChangeRate":0.046516},{"month":11,"riseRate":0.75,"avgChangeRate":0.021182},{"month":12,"riseRate":0.75,"avgChangeRate":0.279121}],"exchange":"NASDAQ","name":"Roivant Sciences Ltd.","nameEN":"Roivant Sciences Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Roivant Sciences Ltd.(ROIV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Roivant Sciences Ltd.(ROIV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Roivant Sciences Ltd.,ROIV,Roivant Sciences Ltd.股票,Roivant Sciences Ltd.股票老虎,Roivant Sciences Ltd.股票老虎国际,Roivant Sciences Ltd.行情,Roivant Sciences Ltd.股票行情,Roivant Sciences Ltd.股价,Roivant Sciences Ltd.股市,Roivant Sciences Ltd.股票价格,Roivant Sciences Ltd.股票交易,Roivant Sciences Ltd.股票购买,Roivant Sciences Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Roivant Sciences Ltd.(ROIV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Roivant Sciences Ltd.(ROIV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况